Phagocyte-induced lipid peroxidation of lung surfactant

Pediatric Pulmonology

Volumn 27, Issue 5, 1999, Pages 322-327

  Bouhafs, Rabea K L ^a   Jarstrand, Connie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antioxidants; Free radicals; Lipid peroxidation; Neutrophils; Surfactant

Indexed keywords

ALPHA TOCOPHEROL; LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; OXYGEN RADICAL;

ARTICLE; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; HUMAN; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; VITAMIN INTAKE;

EID: 0032961212     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199905)27:5<322::AID-PPUL5>3.0.CO;2-E     Document Type: Article

References (43)

1. Avery ME, Merritt TA. Surfactant replacement therapy. N Engl J Med 1991;324:910-912.
2. Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987; 136:1256-1275.
3. Van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev 1988:68:374-455.
4. Richard LA, Robert HN, James WK, Jonathan MD, Donald LS. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991;87:101-107.
5. Robertson B, Curstedt T, Johansson J, Jörnval H, Kobayashi T. Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 1990;25: 237-246.
6. Enhörning G, Shennan A, Possmayer F. Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 1985;76:145-153.
7. Kwong MS, Egan EA, Notter RH, Shapiro DL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985;76:585-592.
8. Shapiro DL, Notter RH, Morin FC III, Deluga KS, Golub LM, Sinkin RA, Weiss KI, Cox C. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics 1985;76:593-599.
9. Merritt TA, Hallman M, Bloom BT, Berry C. Benirschke K, Sahn D, Key T, Edwards D, Jarvenpaa AL, Pohjavnori M. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986;315:785-790.
10. Fujiwara T. Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline membrane disease. Lancet 1980;1:55-59.
11. Notter RH, Shapiro RH, editors. Lung surfactant for replacement therapy: biochemical, biophysical and clinical aspects. Clin Perinatol 1987;14:433-479.
12. Hallman M, Merritt TA, Jarvenpaa AL, Boynton B, Mannino F, Gluck L, Moore T, Edwards D. Exogenous surfactant for the treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr 1985;106:963-969.
13. Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW. Randomized controlled trial of exogenous surfactant treatment of hyaline membrane disease. Pediatrics 1987;79: 31-37.
14. Raju TN, Vidyasagar D, Bhat R, Sobel D, McCulloch KM, Anderson M, Maeta H, Levy PS, Fumer S. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1987;1:651-656.
15. Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 1988; 82:683-691.
16. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W, and American Exosurf Pediatric Study Group 1. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. J Pediatr 1991;118:277-284.
17. Clark DA, Nieman GF, Thompson JE, Paskanik AM, Rokhar JE, Bredenberg CE. Surfactant displacement by meconium free fatty acids: an alternate explanation for atelectasis in meconium aspiration syndrome. J Pediatr 1987;110:765-770.
18. Terasaka D, Clark DA, Singh BN, Rokahr J. Free fatty acids of human meconium. Biol Neonate 1986;50:16-20.
19. Moison RMW, Palinckx JJS, Roest M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993;341:79-82.
20. Holm BA, Enhörning G, Notter RH. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids 1988;49:49-55.
21. Seeger W, Lepper H, Wolf HRD, Neuhof H. Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro. Biochim Biophys Acta 1985;835:58-67.
22. Kobayashi T, Nitta K. Ghanzuka M, Inui S, Grossman G, Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991;29:353-356.
23. Kobayashi T, Nitta K, Takahashi R, Kurashima K, Robertson B, Susuki Y. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J Appl Physiol 1991;71:530-536.
24. Ryan SF, Ghassibi Y, Liau DF. Effect of activated polymorphonuclear leukocytes upon pulmonary surfactant in vitro. Am J Respir Cell Mol Biol 1991;4:33-41.
25. Thomas EL, Lehler RI, Rest RF. Human neutrophil antimicrobial activity. Rev Infect Dis [Suppl] 1988;10:450-456.
26. Florence TM. The role of free radicals in disease. Aust N Z J Ophthalmol 1995;23:3-7.
27. Boyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Invest [Suppl] 1968;21:9.
28. Jarstrand C, Angelin BO, Einarsson K. Decreased nitroblue tetrazolium reduction of granulocytes in type IV hyperlipoproteinemia. Lab Clin Med 1979;897-901.
29. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992;339:466-469.
30. Hogan JS, Smith KL, Weiss WP, Todhunter DA, Schockey WL. Relationships among vitamin E, selenium and bovine neutrophils. J Dairy Sci 1990;73:2372-2378.
31. Herting E, Jarstrand C, Rasool O, Curstedt T, Hånkanson S, Robertson B. Effect of surfactant on NBT reduction of PMN leucocytes stimulated with type Ia group B streptococci. Acta Pediatr 1995;84:922-926.
32. Jarstrand C, Berggren P, Curstedt T, Johansson A, Robertson B, Wiernik A. Influence of lung surfactant phospholipids on neutrophilic granulocytes and blood monocytes. Prog Respir Res 1984; 18:44-50.
33. Speer CP, Götze B, Robertson B, Curstedt T. The effect of natural porcine surfactant on the phagocytosis-associated functions of human neutrophils. In: Cosmi EV, Di Renzo CC, Anceschi MM, editors. The surfactant system of the lung. Prevention and treatment of neonatal and ARDS. London: Macmillan Press; 1991. p 142-150.
34. Speer C. Götze B, Curstedt T, Robertson B. Phagocytic function and NTF secretion of human monocytes exposed to natural porcine surfactant. Pediatr Res 1991;30:69-74.
35. Jarstrand C, Wiernik A, Curstedt T, Sundqvist KG. Lung surfactant inhibits the lipopolysaccharide-induced release of oxygen radicals, enzymes and interleukin-1 from phagocytes. Immun Infect Dis 1991;1:179-182.
36. Yoshida K, Mohsenin V. Inhibition of protein kinase C of human neutrophils by phosphatidylcholines. Life Sci 1994;54:515-524.
37. Ahuya A, Oh N, Chao W, Spragg RG, Smith RM. Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant. Am J Respir Cell Mol Biol 1996;14:496-503.
38. Matalon S, Holm BA, Baker RR, Whitfield MK, Freeman BA. Characterisation of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1990;1035:121-127.
39. Kanno T, Utsumi T, Kobushi H, Takehara Y, Akiyama J, Yoshioka T, Horton AA, Utsumi K. Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. Free Radic Res 1995;22:431-440.
40. Dimitriev LF, Ivanova MV, Lankin VZ. Interaction of tocopherol with peroxyl radicals does not lead to the formation of lipid hydroperoxides in liposomes. Chem Phys Lipids 1994;69:35-39.
41. Freyschuss A. Cholesterol-induced changes in macro- and microvessels in rabbits. Effect of antioxidants. Thesis 1997.
42. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989;140:531-554.
43. Emerit I, Garban F, Vassy J, Levy A, Filipe P, Freitas J. Superoxide-mediated clastogenesis and anticlastogenic effects of exogenous superoxide dismutase. Proc Nat Acad Sci USA 1996;93: 12799-12804.